Drug markers questioned
jane2007 submitted, created time 9 months 6 days (www.nature.com)
A recent spate of worrying clinical-trial data has researchers questioning drugs approved on the basis of how they affect biomarkers rather than clinical endpoints. Heidi Ledford looks at surrogate markers.